| 000 | 01826 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515073740.0 | ||
| 264 | 0 | _c20071019 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0363-6135 | ||
| 024 | 7 |
_a10.1152/ajpheart.00457.2007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGilliam-Davis, Shea | |
| 245 | 0 | 0 |
_aLong-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. _h[electronic resource] |
| 260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cSep 2007 |
||
| 300 |
_aH1327-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAging _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin I _xblood |
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLeptin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xmetabolism |
| 650 | 0 | 4 |
_aMetabolism _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xdrug effects |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 700 | 1 | _aPayne, Valerie S | |
| 700 | 1 | _aKasper, Sherry O | |
| 700 | 1 | _aTommasi, Ellen N | |
| 700 | 1 | _aRobbins, Michael E | |
| 700 | 1 | _aDiz, Debra I | |
| 773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 293 _gno. 3 _gp. H1327-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00457.2007 _zAvailable from publisher's website |
| 999 |
_c17152438 _d17152438 |
||